Grants>Tobacco Control

Cure4Kids for Kids Global eHealth Challenge

Sponsored by St. Jude Children’s Research Hospital, Cure4Kids for Kids is seeking university, high school, middle school, and elementary school students to develop innovative multimedia experiences that educate children about cancer and healthy living for cancer prevention.

Submit a website, video, podcast, app for mobile device, game, or other multimedia project with a focus on the following topics, Cancer & Tobacco or Cancer & Ultraviolet Rays*.

Grand Prize is an Apple iPad and Internship at St. Jude Children’s Research Hospital**
All entries must be submitted online at www.cure4kids.org/challenge
Teams or individuals may enter

Accepting submissions from January 1, 2012 through April 2, 2012

* No purchase necessary. Students 17 years and younger must have mentor or adult sponsor.
** Only students 16 years and older are eligible for internship.

Fellowship in Cancer Communication Research

The Penn Center of Excellence in Cancer Communication Research (CECCR) at the University of Pennsylvania’s Annenberg School for Communication is offering a research fellowship in cancer communication for the Fall 2012 term. This two-year fellowship program offers training in communication research and theory relevant to cancer prevention and control. The advanced, rigorous training and experience provided will prepare the fellows for careers as independent investigators in cancer communication research.

The mission of the NCI-funded CECCR at Penn is to examine how messages from a range of sources in the complex communication environment affect cancer-related behavioral choices, including lifestyle, screening and care-seeking choices. Previous research has included experimental and observational field studies focused on information seeking and scanning concerning cancer, understanding the interaction of public communication and clinical services as they affect cancer-related decisions and outcomes, the effects of news media about genetic information and the effects of anti-smoking and smoking advertising campaigns.

The Penn CECCR Fellows will obtain skills and experience to complement previous advanced work in communication, public health, behavioral science or biomedical research. Fellows with training in communication research can focus on cancer-related training; those with background in cancer research will focus on communication theory and research. Fellows will work closely with mentors in such areas as cancer epidemiology, health policy, behavioral theory, persuasion theory, risk and decision-making, psychophysiology as well as health communication. Fellows will participate in research in cancer communication using survey, experimental, and content analytic methods and will receive guidance in the preparation of manuscripts and career development grants.

Applicants must have training in social science or behavioral research methods and have received a PhD or an equivalent degree from an accredited institution. Applicants with an MD and at least one year of clinical research training will also be considered. To obtain additional information or apply, please contact Joseph Cappella, Ph.D. (215-746-3400, ceccrfellow@asc.upenn.edu), Gerald R. Miller Professor of Communication, Annenberg School for Communication, University of Pennsylvania, 3620 Walnut Street, Philadelphia, PA 19104. If applying, include letter of introduction, CV, and names of 3 references. Applications will be considered on a continuing basis. To be assured of full consideration for a 9/1/2012 start date please respond by February 15, 2012.

Call for Applications: Dr. Alma S. Adams Scholarship for Outreach and Health Communications

Applications are now being accepted for the Dr. Alma S. Adams Scholarship for Outreach and Health Communications to reduce tobacco use among what the American Legacy Foundation calls Priority Populations*. Priority populations are those populations who are disproportionately targeted by the tobacco industry, or who often lack the tools and resources to combat smoking in their communities.

The scholarship, named for founding Legacy board member, Dr. Alma S. Adams will award two $5,000 scholarships to pursue undergraduate or graduate studies at an accredited institution of higher education in the United States. The awards will be granted on a competitive basis for the following: a) a record of commitment to community service on behalf of an underserved community, preferably related to tobacco prevention and/or control and b) the best use of the visual arts, media, creative writing or other creative endeavor to convey culturally appropriate health messages aimed at raising awareness of tobacco’s harmful impact.

Applications will be accepted from January 1, 2012 until April 30, 2012. Awardees will be notified by June 29, 2012.

For more information, email: adamsscholarship@americanlegacy.org.

*Priority populations include residents of low-income communities, U.S. racial/ethnic minorities (African American, Alaska Native, American Indian, Asian, Hispanic/Latino, Native Hawaiian, Pacific Islander; Gay/lesbian/bi-sexual/transgender communities); and other populations that have significantly higher than average smoking prevalence rates.

2012 Pfizer Fellowships in Public Health

The Fellowship in Public Health is intended to support research that fosters academic science, knowledge of public health, and collaborative partnerships between accredited schools or programs of public health and federal, state, and local departments of public health. Institutions interested in this fellowship program must submit research proposals for programs or initiatives that involve chronic disease prevention (e.g., smoking cessation), healthcare costs (e.g., economic costs of counterfeit medicines), preventive medicine, and/or public health preparedness.

Funds Available

One award of up to $100,000, paid over 2 years at $50,000 per year

Application Deadline: February 10, 2012

Awards Announced: By April 1, 2012

Funding Begins: July 2012

Eligibility

Institutions

Must be an accredited US-based academic institution
Must not be located in the State of Vermont
The institution cannot host another recipient of this same award during the proposed term
Senior staff, division heads or department chairs should work on behalf of their institution to prepare and submit an application for consideration

Proposal

Proposals requesting to study any pharmaceutical product are ineligible for MAP awards. Requests to study Pfizer products must to be submitted through our Investigator Initiated Research portal (http://www.pfizer.com/research/investigator/investigator_initiated_research.jsp).
Basic science and/or fundamental research (animal model, in-vivo / in-vitro) are not permissible
Proof of harm or otherwise highly invasive studies (unethical) will not be considered

Fellows

Prospective fellows at the institution CANNOT apply directly for the award. A Fellow may assist the senior staff, division head or department chair at the institution in the development of the grant application
A fellow supported by a Pfizer MAP fellowship must have the opportunity to carry out supervised biomedical or clinical research with the primary objective of preparing them for their respective discipline and subspecialty
Upon receipt of the grant award, the Fellow selected by the Institution must meet the following criteria:
US citizen or foreign national with permanent US residence
Hold an advanced degree (i.e., MD, DO, NP, PharmD, etc.)
Be enrolled in fellowship program (Clinical award recipients)
Hold a non-tenured, junior faculty appointment (Research award recipients)

Selection Process

Quality of the Research Proposal:

Is the proposal innovative, significant, and feasible, and does it have depth?
Does the proposal reference interdisciplinary knowledge?
Does the proposal bridge the academic and practice communities?

Quality of the Institution:

Assessment of the academic and/or medical facilities and the institution's commitment to research.
Are the institutional support, equipment and other physical resources available to the fellow(s) adequate for the proposed project?
Will the project benefit from the unique features of the environment, subject populations, or collaborative arrangements offered by the institution?

Quality of the Mentor(s):

Is the mentor(s) well suited to the project?
What is the mentor(s) experience within the field?
Is the mentoring relationship beneficial for the development of potential fellow?

Contact Us

Questions about the programs and/or applications:

The Pfizer MAP Team
Phone: (877) 254-6953
E-mail: MAPinfo@clinicalconnexion.com

2012 Pfizer Fellowships in Health Disparities

Institutions interested in this fellowship program must focus their research on the cause for these inequalities and develop solutions to address disparities. Research proposals should be focused on smoking-cessation programs, women’s health/gender medicine, and preventive healthcare to address disparities among populations of different races, ethnicities, or age groups, or between low-income versus high-income populations.

Funds Available: One award of up to $100,000, paid over 2 years at $50,000 per year

Application Deadline: February 10, 2012

Awards Announced: By April 1, 2012

Funding Begins: July 2012

Eligibility

Institutions

Must be an accredited US-based academic institution
Must not be located in the State of Vermont
The institution cannot host another recipient of this same award during the proposed term
Senior staff, division heads or department chairs should work on behalf of their institution to prepare and submit an application for consideration

Proposal

Proposals requesting to study any pharmaceutical product are ineligible for MAP awards. Requests to study Pfizer products must to be submitted through our Investigator Initiated Research portal (http://www.pfizer.com/research/investigator/investigator_initiated_research.jsp).
Basic science and/or fundamental research (animal model, in-vivo / in-vitro) are not permissible
Proof of harm or otherwise highly invasive studies (unethical) will not be considered

Fellows

Prospective fellows at the institution CANNOT apply directly for the award. A Fellow may assist the senior staff, division head or department chair at the institution in the development of the grant application
A fellow supported by a Pfizer MAP fellowship must have the opportunity to carry out supervised biomedical or clinical research with the primary objective of preparing them for their respective discipline and subspecialty
Upon receipt of the grant award, the Fellow selected by the Institution must meet the following criteria:
US citizen or foreign national with permanent US residence
Hold an advanced degree (i.e., MD, DO, NP, PharmD, etc.)
Be enrolled in fellowship program (Clinical award recipients)
Hold a non-tenured, junior faculty appointment (Research award recipients)

Selection Process

Quality of the Research Proposal:

Is the proposal innovative, significant, and feasible, and does it have depth?
Does the proposal reference interdisciplinary knowledge?
Does the proposal bridge the academic and practice communities?

Quality of the Institution:

Assessment of the academic and/or medical facilities and the institution's commitment to research.
Are the institutional support, equipment and other physical resources available to the fellow(s) adequate for the proposed project?
Will the project benefit from the unique features of the environment, subject populations, or collaborative arrangements offered by the institution?

Quality of the Mentor(s):

Is the mentor(s) well suited to the project?
What is the mentor(s) experience within the field?
Is the mentoring relationship beneficial for the development of potential fellow?

Contact Us

Questions about the programs and/or applications:

The Pfizer MAP Team
Phone: (877) 254-6953
E-mail: MAPinfo@clinicalconnexion.com

International Cancer Technology Transfer Fellowships

The aim of the UICC ICRETT fellowships is to facilitate rapid international transfer of cancer research and clinical technology, exchange knowledge and enhance skills in basic, clinical, behavioural and epidemiological areas of cancer research cancer control and prevention and to acquire appropriate clinical management, diagnostic and therapeutic expertise for effective application and use in the home organization upon return.

Since its inception in 1976, the ICRETT fellowships have contributed to the development of the professional capacity of over 1425 ICRETT Fellows from over 130 countries by facilitating appropriate person-to-person training in specific areas that are relevant to the cancer research, clinical management and other cancer control activities being conducted in the Fellows’ home countries.

Target candidates Investigators, clinicians, public health professionals

Duration 1 month

Extension Up to 2 months with funding secured by the Fellow from the home or host organization and at no cost to the UICC

Available 120-150 per year

Average value US$ 3,400 each

Application closing date None. Applications are accepted at any time

Notification of results Generally within 60 days of registration

Objectives

* To facilitate rapid international transfer of cancer research and clinical technology
* To exchange knowledge and enhance skills in
o basic, clinical, behavioural and epidemiological areas of cancer research
o cancer control and prevention
* To acquire appropriate clinical management, diagnostic and therapeutic expertise for effective application and use in the home organization upon return

Eligibility

* Appropriately qualified investigators, pathologists, epidemiologists, laboratory technicians, tobacco control activists and cancer registrars in the early stages of their careers
* Appropriately qualified clinicians who are established in oncology practice

Research plan

* Cancer prevention and control (including tobacco control)
* Basic, applied and clinical cancer research
* Epidemiology, cancer registration, public education and behavioural sciences

Clinical training

* Surgery, radio- and chemotherapy, medical oncology, multidisciplinary cancer care
* Clinical trials
* Detection and diagnosis
* Prevention-oriented projects are especially encouraged